BiomX Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BiomX Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($9.17M) | Nov 12, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($6.04M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($6.04M) | Aug 13, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($7.66M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($7.66M) | May 15, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($7.66M) | Nov 12, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $9.64M | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | $4.47M | Aug 13, 2025 |
| Q3 | 2025 | Jun 30, 2024 | $4.47M | Nov 12, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($17.33M) | Nov 12, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($17.33M) | May 15, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($17.33M) | Aug 13, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($7.91M) | Nov 14, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($6.41M) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($6.41M) | Aug 14, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($6.36M) | Aug 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($6.36M) | May 20, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($6.36M) | Nov 14, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($6.78M) | Nov 14, 2023 |
| Q3 | 2023 | Jun 30, 2022 | ($7.48M) | Nov 14, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($8.54M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($7.43M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($7.76M) | May 15, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($11.33M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($9.73M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($6.79M) | May 15, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($7.80M) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($6.07M) | Aug 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($6.21M) | May 20, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($6.55M) | Nov 14, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($7.32M) | Aug 9, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($7.79M) | May 15, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($9.83M) | Nov 9, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($7.30M) | Aug 10, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($8.54M) | May 11, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($8.83M) | Nov 15, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($6.39M) | Aug 16, 2021 |
| Q1 | 2021 | Mar 31, 2020 | ($5.97M) | May 24, 2021 |
| Q1 | 2020 | Sep 30, 2019 | ($618.9K) | Oct 16, 2019 |
| Q3 | 2020 | Sep 30, 2019 | ($4.66M) | Nov 12, 2020 |